Taking part in research is vital for science to progress, for the people affected by a health condition, and for future generations.

Health research and clinical trials is more than taking medications and spending time being assessed; it involves many stakeholders including patients, carers, clinicians, funding organisations and governing bodies in prioritising, designing and delivering research results.

At Cure Parkinson’s we are focused on improving the clinical trials process to expedite better treatments for people living with Parkinson’s.


News

Research news

Exploring Perspectives on Trial Design for Parkinson’s: An Update on the Delphi Study

Recently, Cure Parkinson’s was pleased to see the results of one of our funded studies published in the Journal of Parkinson’s Disease.

Research news

Our research impact

Our recent research impact report determines and highlights the impact our research funding has had on the Parkinson’s research field.

News

Research news

The new Multi-arm Multi-stage MAMS trial model for Parkinson’s

One of the most frustrating aspects of the way we currently conduct clinical trials is the long delays between studies. Multi-Arm, Multi-Stage (or MAMS) clinical trials may represent a…

News

Research events

Research Update Meeting Spring 2023 – recorded to watch again

Our popular and much-awaited research update meeting brought together two leading clinicians to report on their individual area of expertise for Parkinson’s. It’s available to watch again!

News

Research news

The 2022 International Linked Clinical Trials meeting

Cure Parkinson’s annually coordinates the International Linked Clinical Trials (iLCT) meeting to rank and prioritise therapies that may have the potential to modify the course of Parkinson’s progression.

News

Research news

The 2022 Parkinson’s drug development pipeline report

The 2022 annual report, outlining the current development pipeline of new drug-based treatments for Parkinson’s, has been published.

News

Research news

Parkinson’s Clinical Study Group

Cure Parkinson’s is funding Professor Oliver Bandmann at the University of Sheffield to establish a nationwide infrastructure for a study group focused specifically on conducting clinical trials for Parkinson’s….

MAMS

News

Research news

Improving Parkinson’s Trials: A Delphi Study

Under the visionary leadership of Dr Camille Carroll at the University of Plymouth, Cure Parkinson’s has been supporting an exploratory study at the University of Plymouth to understand the…

MAMS Trials

News

Research news

Multi-Arm Multi-Stage – a new approach to clinical trials

One of the most frustrating aspects of clinical trials is the long delays between studies. Dr Camille Carroll is leading a group of researchers exploring the use of multi-arm…

MAMS

News

Research news

Multi-Arm Multi-Stage trials for Parkinson’s

At present, most clinical trials for Parkinson’s involve a single therapy, being tested against a ‘placebo’ or control treatment for a fixed period of time.  At the end of…